BELLUS HEALTH INC (BLU)
CA07987C2040 - Common Stock
Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health
/CNW/ - GSK plc (LSE: GSK) (NYSE: GSK) and BELLUS Health Inc. (TSX: BLU) NASDAQ: BLU) today announced GSK has completed the acquisition of BELLUS, a...
BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
Big Pharma is facing a patent cliff that could siphon off billions in revenue.
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
GSK Stock: A Value Trap or a Hidden Gem?
GSK, formerly known as GlaxoSmithKline, is struggling after a complicated earnings season. Here's why GSK stock is still a buy.
BELLUS Health Announces Meeting Updates
3 Biotechs That Might Get Bought Out in 2023
Biotech is expected to be a hotbed of mergers and acquisitions this year.
Was This Acquisition a Savvy Play by This Big Pharma Stock?
The British drugmaker picked up a potential blockbuster drug in its deal for Bellus Health.
Moore Kuehn Encourages BLU, STSA, RXDX, STSA, and CHRA Investors to Contact Law Firm
/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...
Why This Nasdaq Stock Caught Fire This Week
A wave of bargain buying benefited the gene therapy company's shares this week.
Why Shares of Bellus Health Skyrocketed This Week
The company has received a buyout offer from GSK.
Beaten-Down Biotech Stocks Get Boost from M&A Boom, Lofty Prices
The resurgence of deal activity in the drug-development industry is driving investors’ interest in biotech stocks and boosting values for potential takeover targets.
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
Why BELLUS Health Stock Is Rocketing Higher Today
A $2 billion buyout agreement with GSK is lighting a fire under the biotech's stock today.
Bellus Health Soars 98% As GSK Joins Buyout Bonanza With $2 Billion Deal
Shares of its takeover candidate nearly doubled on the news.
Why Is Gamida Cell (GMDA) Stock Up 48% Today?
Gamida Cell (GMDA) stock is taking off on Tuesday after getting an update from the FDA concerning cell therapy Omisirge.
Why Is ContraFect (CFRX) Stock Down 14% Today?
ContraFect (CFRX) stock is dropping on Tuesday after the company revealed a notice from the Nasdaq Exchange and undergoing a rally yesterday.
Why Is Bellus Health (BLU) Stock Up 98% Today?
Bellus Health (BLU) stock is taking off on Tuesday after the company announced a $2 billion acquisition deal with GSK (GSK).
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off the day with a look at the biggest pre-market stock movers traders will want to keep an eye on Tuesday!
Bellus Health stock posts early stage data for cough candidate
Bellus Health (BLU) posted Phase 1 data for its cough candidate camlipixant Wednesday highlighting results as an indication of its proof of concept. Read more here.